Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone. - Wikidata - awgldk - TriplyDB

Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.

Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.

http://www.wikidata.org/entity/Q35935409

about

UK guidelines for the management of bone sarcomas Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone Advances in sarcoma diagnostics and treatment Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma.Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.From Bench to Bedside: Targeted Therapy, Denosumab, and 21st Century Orthopaedics: Targets Abound, But Where Are The Therapies?Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.Denosumab treatment of inoperable or locally advanced giant cell tumor of bone.Giant Cell Tumor Developing in Paget's Disease of Bone: A Case Report with Review of Literature.Future Advances in Spine Surgery: The AOSpine North America Perspective.Clinical and Radiographic Results of Reconstruction with Fibular Autograft for Distal Radius Giant Cell Tumor.How safe and effective is denosumab for bone giant cell tumour?Combining of serial embolization and denosumab for large sacropelvic giant cell tumor: Case report of 3 cases.Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report The distinct clinical features of giant cell tumor of bone in pagetic and non-pagetic patients are associated with genetic, biochemical and histological differences.Giant cell tumor of the bone: aggressive case initially treated with denosumab and intralesional surgery.Giant cell tumour of the distal radius/ulna: response to pre-operative treatment with short-term denosumab.Treatment results of adult patients with primary bone tumours of the humerus with the use of the oncological modular endoprosthesis.Risk factors for postoperative deep infection in bone tumors.Development of high-grade osteosarcoma in a patient with recurrent giant cell tumor of the ischium while receiving treatment with denosumab.Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.Spine Oncology - Primary Spine Tumors.Assessment of denosumab treatment effects and imaging response in patients with giant cell tumor of bone Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study

P2860

Q26752425-79FF52C1-9ED5-49E1-9BE1-C50F61094DF0 Q28066533-55B47198-9DA2-4AE8-99CC-14F9B557ED19 Q28069695-C97B75FC-9C06-44AA-8544-1247F89B00EC Q33276109-99AE9484-9719-49EB-A89A-F3410FBF42B3 Q36181563-2003719B-8011-4295-8DCC-6F2F307E2FE6 Q36636955-96E9CC2A-ECC2-47D5-A1BB-C37D79C4D263 Q37117997-63B0D55C-6563-41E7-A3FB-6D305F82FD61 Q37581613-BAB861D4-37F9-4687-ADCF-B51F42C1CA01 Q37620373-A44413B5-8F0C-4583-B47A-113C7041D51D Q38738480-236B8A9D-AF18-472F-8447-4D3EBC6862BA Q38888177-0342D34C-6B91-406C-B020-D03A6D927FC2 Q39395512-C5E01CC5-90A1-4DF3-BADE-A64F3E3EA8F0 Q41521555-792B3E18-16C5-4D17-B8A1-E6C723461449 Q42042281-C1B9C5BA-59AD-44E2-8D67-AFDB0CD8D39B Q42362651-8B71BFC8-05F6-417A-99F2-2E2936D39F2F Q46775047-2A0D3FCA-6F0E-4DB6-80B4-C7FAEACAC1D6 Q47098512-42F039B9-5232-415E-9293-E02470D2891A Q47103342-753E9CC8-713E-4455-8543-4BA8F845687D Q47384136-15585CF5-06CD-446E-8103-00A88F70790A Q50094913-E1AFAD07-276E-418A-A365-D9BEAEF82E71 Q51064173-7BBA62F7-99F0-4CCD-8D80-AA2456CF3A71 Q52695440-9B5E2F70-0796-46F0-B7F1-6C83F7C69A1F Q58718973-4E9D6EBA-BEA5-410D-B8A4-7516DAABCFFA Q58795764-CE331D04-1D3B-48C1-B25B-14A285D1681B

P2860

Surgical downstaging in an open-label phase II trial of denosumab in patients with giant cell tumor of bone.

http://www.wikidata.org/entity/Q35935409

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Surgical downstaging in an ope ...... with giant cell tumor of bone.

@ast

Surgical downstaging in an ope ...... with giant cell tumor of bone.

@en

type

label

Surgical downstaging in an ope ...... with giant cell tumor of bone.

@ast

Surgical downstaging in an ope ...... with giant cell tumor of bone.

@en

prefLabel

Surgical downstaging in an ope ...... with giant cell tumor of bone.

@ast

Surgical downstaging in an ope ...... with giant cell tumor of bone.

@en

P1433

Q35935409-6B8379A2-66A4-40EC-A014-88203911EBE1

P1476

Q35935409-D1CB1540-95A3-4966-89F5-D7995D830E73

P2093

Q35935409-0708221E-510B-4613-8BF8-F03452A3F3C6

Q35935409-4B21441F-9E59-46C8-9FC1-1CA22C4C7EAD

Q35935409-4F2E2CA2-3DBB-496F-9344-C3E2560A4627

Q35935409-5254E91E-6224-4A1C-9996-1141AF7A13FF

Q35935409-57CC6871-2959-4469-BF86-00E1AF09028E

Q35935409-6CB1D475-2BF3-4EBC-82C4-5FB45018F216

Q35935409-7000B95D-37A9-4FAE-8CC5-CD230D4D0250

Q35935409-894D374C-26AA-4D8C-B5C9-DBC9BE8DC5D0

Q35935409-9B69AC6F-DC02-4861-8034-1B0557051B0E

Q35935409-A5A77E06-8DB0-4642-874F-3B93C3932C5B

P2860

Q35935409-11D83519-81BD-4EAD-826E-DC7F26D5C4DA

Q35935409-213AA136-C8D3-4D40-AE03-BE2745F58580

Q35935409-2ED8883C-D0C2-47E6-993C-37360EC02529

Q35935409-32A3036F-6E26-40D5-B3EE-4824372E4003

Q35935409-3F9BFE02-8FDB-494A-887A-EF2D3ECFA732

Q35935409-53A5A4BE-0EAC-4675-81D8-CCFBC3CD908D

Q35935409-560E2A94-23F2-476D-A57F-353491776BBC

Q35935409-653DC94E-A27A-4AE8-8E91-C4E03F00A3D9

Q35935409-80C3602F-BBF9-4F67-915F-52895EE636C0

Q35935409-88B46F33-9832-4B8F-8AE0-F14E6F285C08

P2888

Q35935409-5AB2F170-12C6-4F80-BD38-8D55B91A937F

P304

Q35935409-5975CA11-1462-4BDB-908A-817C29B622AC

P31

Q35935409-08BB5750-F7C0-4129-ABBB-34F3AEC1BA3E

P356

Q35935409-6DC1F3C4-B142-4E0C-B3D6-1611203CA86F

P433

Q35935409-0314A4DD-DFF4-4EFE-8F16-FCE119D6C3F2

P478

Q35935409-7D029BDF-849F-4155-AAFB-FA6BF8E611DC

P50

Q35935409-D7BC9437-B353-4144-871F-349D8DCE6E0C

P577

Q35935409-BFA3E79E-D4E7-4279-BD4A-CF82877228AE

P5875

Q35935409-549DD5BD-C438-4F77-AC38-FBA98C327FBE

P6179

Q35935409-21D6BD93-38AA-4473-8FFF-DF3436734582

P698

Q35935409-C553C2ED-46AA-4289-AF39-3C772F5D5CD9

P921

Q35935409-3E8589AF-116A-4D61-AD2F-411F7B670DBE

P932

Q35935409-DC6F149C-31D2-41B7-8C7F-01C68F744C67

P356

S10434-015-4634-9

P1433

Annals of Surgical Oncology

P1476

Surgical downstaging in an ope ...... with giant cell tumor of bone.

@en

P2093

Amy Feng

http://www.w3.org/2001/XMLSchema#string

Andrzej Pienkowski

http://www.w3.org/2001/XMLSchema#string

Bruce A Bach

http://www.w3.org/2001/XMLSchema#string

Gualter Vaz

http://www.w3.org/2001/XMLSchema#string

Jay S Wunder

http://www.w3.org/2001/XMLSchema#string

Leanne L Seeger

http://www.w3.org/2001/XMLSchema#string

Paul D Stalley

http://www.w3.org/2001/XMLSchema#string

Robert J Grimer

http://www.w3.org/2001/XMLSchema#string

Sander P D Dijkstra

http://www.w3.org/2001/XMLSchema#string

Stefano Ferrari

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

The clinical approach toward giant cell tumor of bone

Giant cell tumor of bone: treatment and outcome of 214 cases

Cryosurgery in the treatment of giant cell tumor. A long-term followup study.

Giant-cell tumour of bone metastasising to the lungs. A long-term follow-up.

Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy

Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB

Giant-cell tumour of bone.

Giant cell tumour of bone.

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.

P2888

s10434-015-4634-9

P304

2860-2868

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-015-4634-9

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

Piotr Rutkowski

P577

2015-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277600823

http://www.w3.org/2001/XMLSchema#string

P6179

1026452907

http://www.w3.org/2001/XMLSchema#string

P698

26033180

http://www.w3.org/2001/XMLSchema#string

P921

phase II clinical trial

P932

4531146

http://www.w3.org/2001/XMLSchema#string